Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone. Another day is upon us. But this is a good thing. As one of our favorite sages, the Morning Mayor, used to say: Every brand new day should be unwrapped like a precious gift. While you tug on the ribbon, we will brew the mandatory cup of stimulation and poke around for interesting items. Here, in fact, are a few to help you get started. Have a good one and stay in touch...

Roche Rules Out Merging R&D With Genentech (Reuters)

Abbott To Close Canadian Baby Formula Plant (Brockville Recorder & Times)

China's BGI And Merck Form Alliance (Bio-IT World)

Abbott Fights To Keep Meridia Diet Pill On The Market (Reuters)

K-V Pharmaceutical Secures A $20M Loan (Fox Business)

Genentech CEO Resigns From Dendreon Board (Xconomy)

Cell Therapeutics Appeals FDA Rejection (PharmaTimes)

FDA Approves Savient Pharma Gout Drug (Bloomberg News)

Synthetech Is Acquired For $19.2M By WR Grace (Xconomy)

Neurocrine Experimental Drug Failed To Ease Depression (Associated Press)

Pfizer Investigates Rusty Spring In Baby Milk (Dairy Farmer)